Diorganotin(IV) Complexes with Binary Schiff-Bases
night, afterwards it was filtered through Celite. The filtrate was evapo- package. Three carbon atoms (C32, C33, and C34) of one of the tin-
rated to dryness under reduced pressure. The residue was recrystallized bound butyl groups were found to be disordered, and were refined with
from acetonitrile to give compound 1 as fine block orange-red crystals the site occupy factors 0.49 and 0.51. A summary of crystal data and
suitable for X-ray diffraction. Yield: 0.483 g, 70 %. Elemental analy- refinement parameters is given in Table 1.
sis: C38H52N2O2Sn (687.54): calcd. C 66.38; H 7.62; N 4.07 %; found
C 66.20; H 7.51; N 4.25 %. IR (KBr): ν = 3055 m, 1611 s, 1607 s,
˜
Table 1. Details of the X-ray data collections and refinements of com-
pound 1.
1
607 m, 579, 481 m cm–1. H NMR (300 MHz, CDCl3, 297 K): δ =
0.66 [t, 6 H, Sn–(CH2)3CH3], 0.83–1.51 [m, 12 H, Sn–(CH3)3–], 1.41
Formula
C38H52N2O2Sn
(s 18 H, Ar–tBu), 2.06 (s, 6 H, Ar–CH3), 6.73–7.41 (m, 8 H, Ar–H),
8.41 (s, 2 H, CH=N). 13C NMR (75 MHz, CDCl3, 297 K): δ = 168.7 Crystal system
Monoclinic
0.35 x 0.30 x 0.25
P21/c
Crystal size / mm
Space group
a /Å
(CH=N), 163.2, 147.9, 141.6, 138.0, 132.4, 130.0, 127.1, 123.5, 117.4
(Ar–C), 34.5, 30.1, 28.0, 26.8, 25.9, 19.6, 13.1 (aliphatic–C). 119Sn
NMR (33.35 MHz, CDCl3, 297 K): δ = –427.
23.167(3)
7.8214(11)
20.415(3)
105.717(2)
3560.8(9)
4
b /Å
c /Å
β /°
Preparation of (PhCH2)2SnL1 (2)
V /Å3
Z
The preparation follows the procedure described for compound 1.
Yield 76 %. Elemental analysis: C44H48N2O2Sn (755.57): calcd. C
Diffractometer
Temperature /K
μ (radiation used) /cm–1
Trans. factors
Dcalcd /g·cm–3
F(000)
CCD area detector
273(2)
0.751
69.94; H 6.40; N 3.71 %; found C 69.81; H 6.55; N 3.77 %. IR (KBr):
1
ν = 3057 m, 1613 vs, 596 m, 568, 447 m cm–1. H NMR (300 MHz,
˜
CDCl3, 297 K): δ = 1.39 (s, 18 H, Ar–tBu), 2.07 (s, 6 H, Ar–CH3),
1.282
1440
25.03
2.73 (s, 4 H, PhCH2–), 6.72–7.49 (m, 18 H, Ar–H), 8.33 (s, 2 H, CH=
N). 13C NMR (75 MHz, CDCl3, 297 K): δ = 167.1 (CH=N), 163.8, θmax /°
Reflns meas.
149.6, 144.8, 143.7, 137.6, 133.4, 132.5, 128.3, 127.5, 126.4, 124.1,
123.9, 116.8 (Ar–C), 34.1, 30.5, 19.3 (aliphatic–C), 30.1 (PhCH2Sn).
119Sn NMR (33.35 MHz, CDCl3, 297 K): δ = –477.
Reflns unique, Rint
Reflns with I ≥ nσ(I)
Weighting Scheme
R(F or F2), Rw(F or F2)
ρ /e·Å–3
6280,0.0924
5307
calcd.
0.0358, 0.0953
0.592, –0.715
SHELXS-97
Preparation of nBu2SnL2 (3)
Programs used
The preparation follows the procedure described for compound 1.
Yield 81 %. Elemental analysis: C28H32N2O2Sn (547.27): calcd. C
66.45; H 5.89; N 5.12 %; found C 66.37; H 5.91; N 5.20 %. IR (KBr):
˜
Crystallographic data for the structures have been deposited with
the Cambridge Crystallographic Data Centre, 12 Union Road, Cam-
bridge CB21EZ. Copies of the data can be obtained on quoting
the depository numbers CCDC-749851. (Fax: +44-1223-336-033;
E-Mail: deposit@ccdc.cam.ac.uk).
1
ν = 3047 m, 1608 vs, 605 m, 574, 487 m cm–1. H NMR (300 MHz,
CDCl3, 297 K): δ = 0.63 [t, 6 H, Sn–(CH2)3CH3], 0.84–1.53 [m, 12
H, Sn–(CH3)3], 6.67–7.54 (m, 12 H, Ar–H), 8.47 (s, 2 H, CH=N). 13C
NMR (75 MHz, CDCl3, 297 K): δ = 170.2 (CH=N), 161.8, 144.6,
138.1, 136.6, 129.7, 124.5, 120.6, 119.4, 115.3 (Ar–C), 29.7, 26.5,
25.4, 14.8 (aliphatic–C). 119Sn NMR (33.35 MHz, CDCl3, 297 K):
δ = –419.
Acknowledgement
This work was supported by the S&R Project-Starting Off Found of
JMC.
Preparation of (PhCH2)2SnL2 (4)
The preparation follows the procedure described for compound 1.
Yield 70 %. Elemental analysis: C34H28N2O2Sn (615.31): calcd. C
References
66.37; H 4.59; N 4.55 %; found C 66.34; H 4.46; N 4.61 %. IR (KBr):
1
ν = 3061 m, 1612 vs. 595 m, 557, 451 m cm–1. H NMR (300 MHz,
˜
[1] B. Y. K. Ho, J. J. Zuckerman, Inorg. Chem. 1973, 12, 1552.
[2] A. J. Crowe, P. J. Smith, G. Attasi, Chem. Biol. Interact. 1980,
32, 171.
CDCl3, 297 K): 2.81 (s, 4 H, PhCH2–), 6.73–7.52 (m, 22 H, Ar–H),
8.45 (s, 2 H, CH=N). 13C NMR (75 MHz, CDCl3, 297 K): δ = 169.3
(CH=N), 161.6, 144.8, 142.3, 138.1, 136.0, 130.5, 129.5, 127.9, 126.1,
124.3, 121.6, 118.7, 115.4 (Ar–C), 30.7 (PhCH2Sn). 119Sn NMR
(33.35 MHz, CDCl3, 297 K): δ = –457.
[3] A. J. Crowe, P. J. Smith, J. Organomet. Chem. 1982, 224, 223.
[4] A. J. Crowe, P. J. Smith, C. J. Cardin, H. E. Parge, F. E. Smith,
Cancer Lett. 1984, 24, 45.
[5] F. Huber, G. Roge, L. Carl, G. Atassi, F. Spreafico, S. Filippeschi,
R. Barbieri, A. Silvestri, E. Rivarola, G. Ruisi, F. D. Bianca, G.
Alonzo, J. Chem. Soc. Dalton Trans. 1985, 523.
X-ray Crystallographic Study
[6] N. K. Goh, C. K. Chu, L. E. Khoo, D. Whalen, G. Eng, F. E.
Smith, R. C. Hynes, Appl. Organomet. Chem. 1987, 1, 507.
[7] A. J. Crowe, Drugs Future 1987, 12, 40.
Intensity data of compound 1 were collected with a Bruker AXS Smart
1000 CCD diffractometer, and corrected for absorption and other ef-
fects using Mo-Kα radiation (0.71073 Å) at 293 K. The structures were
solved by direct methods and refined by full-matrix least-squares based
on F2. All non-hydrogen atoms were given anisotropic displacement
parameters. Hydrogen atoms were placed in calculated positions. The
calculations were performed by using the SHELXTL-97 [24] program
[8] A. K. Saxena, F. Huber, Coord. Chem. Rev. 1989, 95, 109.
[9] R. S. Collinson, D. E. Ferton, Coord. Chem. Rev. 1996, 148, 19.
[10] H. D. Yin, Q. B. Wang, S. C. Xue, J. Organomet. Chem. 2004,
689, 2480.
[11] H. D. Yin, Q. B. Wang, S. C. Xue, J. Organomet. Chem. 2005,
690, 435.
Z. Anorg. Allg. Chem. 2010, 861–864
© 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
863